LONDON (Reuters) – A single dose of Pfizer and BioNtech’s COVID-19 vaccine reduces the number of asymptomatic infections and could significantly reduce the risk of virus transmission, results of a UK study …
Read More »
By John Miller, Ludwig Burger ZURICH (Reuters) – Vaccines from AstraZeneca, Russia’s Gamaleya Institute and Johnson & Johnson fight the coronavirus with another virus, leaving scientists concerned that the vaccines could lose …
Read More »
FILE PHOTO: The President of the European Commission, Ursula von der Leyen, gives a press conference on the EU’s biodefense readiness program aimed at increasing the bloc’s capabilities to identify variants of …
Read More »
TOKYO, Feb.22 (Reuters) – Japan will only receive limited doses of COVID-19 vaccines during the first months of the launch of the inoculation and vaccines for the elderly will be gradually distributed, …
Read More »
TOKYO, Feb 16 (Reuters) – Japan is scrambling to secure special syringes to maximize the number of COVID-19 vaccine injections used in each vial, but manufacturers are scrambling to ramp up production …
Read More »
MILAN (Reuters) – The European drug regulator plans to speed up evaluations of any COVID-19 vaccine that is modified to protect against variants of the virus, the head of the agency’s COVID-19 …
Read More »
LONDON (Reuters) – The coronavirus variant first found in Britain’s Kent region is concerning because it is mutating and could undermine the protection provided by vaccines against the development of COVID-19, the …
Read More »
By Alexander Winning, Olivia Kumwenda-Mtambo JOHANNESBURG (Reuters) – The African Union (AU) will not “walk away” from AstraZeneca’s COVID-19 vaccine, but will instead target its use in countries that have not reported …
Read More »
Feb 10 (Reuters) – Shares of cannabis companies rose on Wednesday, extending a month-long rally on bets on decriminalization under the Biden administration, as the Reddit trading community behind a recent trading …
Read More »